102 related articles for article (PubMed ID: 27531787)
21. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
[TBL] [Abstract][Full Text] [Related]
22. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
24. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
[TBL] [Abstract][Full Text] [Related]
25. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
van den Born BJ; van der Hoeven NV; Groot E; Lenting PJ; Meijers JC; Levi M; van Montfrans GA
Hypertension; 2008 Apr; 51(4):862-6. PubMed ID: 18332284
[TBL] [Abstract][Full Text] [Related]
26. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
Song J; Lee KA; Park TS; Park R; Choi JR
Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
[TBL] [Abstract][Full Text] [Related]
27. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.
Groeneveld DJ; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
Br J Surg; 2016 May; 103(6):735-743. PubMed ID: 27005894
[TBL] [Abstract][Full Text] [Related]
28. Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
Singh K; Kwong AC; Madarati H; Kunasekaran S; Sparring T; Fox-Robichaud AE; Liaw PC; Kretz CA
PLoS One; 2021; 16(2):e0247017. PubMed ID: 33606732
[TBL] [Abstract][Full Text] [Related]
29. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome.
Constantinescu-Bercu A; Kessler A; de Groot R; Dragunaite B; Heightman M; Hillman T; Price LC; Brennan E; Sivera R; Vanhoorelbeke K; Singh D; Scully M
J Thromb Haemost; 2023 Jan; 21(1):94-100. PubMed ID: 36695401
[TBL] [Abstract][Full Text] [Related]
30. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
[TBL] [Abstract][Full Text] [Related]
31. [Changes of ADAMTS13 activity and vWF antigen level in patients with acute myelogenous leukemia and their significance].
Zhang WJ; Han Y; Ma ZN; Wang Q; Tang YQ; Wang J; Su J; Sun AN; Wang ZY; Ruan CG; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1503-7. PubMed ID: 25543464
[TBL] [Abstract][Full Text] [Related]
32. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
[TBL] [Abstract][Full Text] [Related]
33. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
34. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
[TBL] [Abstract][Full Text] [Related]
35. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
[TBL] [Abstract][Full Text] [Related]
36. ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis.
Feys HB; Canciani MT; Peyvandi F; Deckmyn H; Vanhoorelbeke K; Mannucci PM
Br J Haematol; 2007 Aug; 138(4):534-40. PubMed ID: 17608762
[TBL] [Abstract][Full Text] [Related]
37. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
38. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.
Rutten B; Maseri A; Cianflone D; Laricchia A; Cristell NA; Durante A; Spartera M; Ancona F; Limite L; Hu D; Li H; Uren NG; de Groot PG; Mannucci PM; Roest M
Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):64-74. PubMed ID: 24833640
[TBL] [Abstract][Full Text] [Related]
39. Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.
Ekaney ML; Bockmeyer CL; Sossdorf M; Reuken PA; Conradi F; Schuerholz T; Blaess MF; Friedman SL; Lösche W; Bauer M; Claus RA
Mol Med; 2015 Apr; 21(1):355-63. PubMed ID: 25860876
[TBL] [Abstract][Full Text] [Related]
40. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
